Sorrento Therapeutics (SRNEQ) vs. Its Competitors Head-To-Head Analysis
Insider and Institutional Ownership 0.0% of Sorrento Therapeutics shares are held by institutional investors. Comparatively, 40.7% of shares of all “Biological products, except diagnostic” companies are held by institutional investors. 2.6% of Sorrento Therapeutics shares are held by insiders. Comparatively, 16.9% of shares of all “Biological products, except diagnostic” companies are held by insiders. Strong […]
17 Nov 05:12 · The Markets Daily